中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 9
Sep.  2018
Turn off MathJax
Article Contents

Level of high-mobility group box 1 in patients with chronic hepatitis B and liver cirrhosis and its clinical significance

DOI: 10.3969/j.issn.1001-5256.2018.09.015
  • Received Date: 2018-04-25
  • Published Date: 2018-09-20
  • Objective To investigate the correlation of serum high-mobility group box 1 (HMGB1) level with hepatic inflammatory activity, liver fibrosis degree, and liver function parameters in chronic hepatitis B patients. Methods A total of 73 patients with chronic hepatitis B and liver cirrhosis were enrolled as subjects. Liver biopsy was performed to determine inflammatory activity and liver fibrosis degree, liver function parameters and serum HMGB1 level were measured, and the correlation between HMGB1 level and other indices was analyzed. The t-test was used for comparison between two groups, and a linear correlation analysis was performed to investigate the correlation between two indices. Results The patients with chronic hepatitis B and liver cirrhosis had a significantly higher HMGB1 level than the healthy control group (29. 46 ± 7. 54 ng/ml vs 16. 86 ± 3. 48 ng/ml, t = 5. 668, P < 0. 01) . The G3-G4 group had a significantly higher HMGB1 level than the G1-G2 group (t = 4. 441, P < 0. 01) , while there was no significant difference in HMGB1 level between the S1-S2 group and the S3-S4 group (t = 0. 658, P > 0. 05) . Serum HMGB1 level was positively correlated with alanine aminotransferase (r = 0. 256 6, P = 0. 028 4) and aspartate aminotransferase (r = 0. 471 9, P < 0. 000 1) , while it was not correlated with albumin or total bilirubin (both P > 0. 05) . Conclusion Serum HMGB1 level is closely correlated with hepatic inflammatory activity.

     

  • loading
  • [1]GOODWIN GH, JOHNS EW.Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids[J].Eur J Biochem, 2010, 40 (1) :215-219.
    [2]WANG H, BLOOM O, ZHANG M, et al.HMG-1 as a late mediator of endotoxin lethality in mice[J].Science, 1999, 285 (5425) :248-251.
    [3]GARDELLA S, ANDREI C, FERRERA D, et al.The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway[J].Embo Rep, 2002, 3 (10) :995-1001.
    [4]SEMINO C, ANGELINI G, POGGI A, et al.NK/i DC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1[J].Blood, 2005, 106 (2) :609-616.
    [5]PALUMBO R, SAMPAOLESI M, MARCHIS FD, et al.Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation[J].J Cell Biol, 2004, 164 (3) :441-449.
    [6]FIUZA C, BUSTIN M, TALWAR S, et al.Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells[J].Blood, 2003, 101 (7) :2652-2660.
    [7]HORI O, BRETT J, SLATTERY T, et al.The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin.Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system[J].J Biol Chem, 1995, 270 (43) :25752-25761.
    [8]YF L, CM C.Hepatitis B virus infection[J].Lancet, 2009, 373 (3) :582-592.
    [9]ALBAYRAK A, UYANIK MH, CERRAH S, et al.Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment[J].Viral Immunol, 2010, 23 (6) :633-638.
    [10]UIF A, WANG H, KARIN P, et al.High Mobility Group 1 Protein (Hmg-1) stimulates proinflammatory cytokine synthesis in human monocytes[J].J Exp Med, 2000, 192 (4) :565-570.
    [11]SHA Y, ZMIJEWSKI J, XU Z, et al.HMGB1 develops enhanced proinflammatory activity by binding to cytokines[J].J Immunol, 2008, 180 (4) :2531-2537.
    [12]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
    [13]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline for prevention and treatment of viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.
    [14]GUO JS.The critical importance of diagnosing and treating liver fibrosis[J].J Clin Hepatol, 2018, 30 (1) :16-19. (in Chinese) 郭津生.重视肝纤维化的诊治[J].临床肝胆病杂志, 2018, 30 (1) :16-19.
    [15]WEI XH, MA LX, FAN ZP, et al.The difference of cell death biomarker M65 at difference liver fibrosis stages of chronic hepatitis B[J].Int J Virol, 2017, 24 (6) :361-364. (in Chinese) 韦新焕, 马丽霞, 范作鹏, 等.细胞死亡标记物M65在慢性乙型肝炎患者不同肝脏纤维化分组间的差异比较[J].国际病毒学杂志, 2017, 24 (6) :361-364.
    [16]LI Y, LU LG.Molecular basis of hepatic fibrosis and current status of its diagnosis and treatment[J].J Clin Hepatol, 2018, 34 (1) :12-16. (in Chinese) 李妍, 陆伦根.肝纤维化的分子基础与临床诊治现状[J].临床肝胆病杂志, 2018, 34 (1) :12-16.
    [17]HU YB, HU DP, FU RQ.Correlation between high mobility group box-1 protein and chronic hepatitis B infection with severe hepatitis B and acute-on-chronic liver failure:A meta-analysis[J].Minerva Med, 2016, 108 (3) :268-276.
    [18]INKAYA AC, DEMIR NA, KOLGELIER S, et al.Is serum highmobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?[J].Medicine, 2017, 96 (36) :e7547.
    [19]LI J, WANG FP, SH WM, et al.Enhanced high-mobility group box1 (HMGB1) modulates regulatory T cells (Treg) /T helper 17 (Th17) balance via toll-like receptor (TLR) -4-interleukin (IL) -6 pathway in patients with chronic hepatitis B[J].J Viral Hepat, 2014, 21 (2) :129-140.
    [20]GE WS, WU JX, FAN JG, et al.Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells[J].World J Gastroenterol, 2011, 17 (36) :4090-4098.
    [21]LIU HB, FAN XG, HUANG JJ, et al.Serum level of HMGB1 in patients with hepatitis B and its clinical significance[J].Chin JHepatol, 2007, 15 (11) :812-815. (in Chinese) 刘洪波, 范学工, 黄建军, 等.乙型肝炎患者血清高迁移率族蛋白-1含量的检测及临床意义[J].中华肝脏病杂志, 2007, 15 (11) :812-815.
    [22]LI L, CHEN N, HE L, et al.Significance of P53 and high mobility group box 1 protein in different levels of liver fibrosis in chronic hepatitis B[J].J Cent South Univ:Med Sci, 2015, 40 (11) :1217-1222. (in Chinese) 李莉, 陈念, 何柳, 等.P53和高迁移率族蛋白-1在不同程度慢性乙型肝炎后肝纤维化组织中的含量及其意义[J].中南大学学报:医学版, 2015, 40 (11) :1217-1222.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2171) PDF downloads(354) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return